Vir Biotechnology IncNASDAQ:VIR
- LAST PRICE7.7400
- TODAY'S CHANGE (%)0.4100 (5.5935%)
- Bid / Lots7.5200/ 1
- Ask / Lots7.7800/ 22
- Open / Previous Close7.4400 / 7.3300
- Day Range
- 52 Week Range
- Volume835,967
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | VIR |
|---|---|---|
| 09:32 ET | 6438 | 7.53 |
| 09:34 ET | 1269 | 7.5173 |
| 09:36 ET | 200 | 7.4836 |
| 09:38 ET | 100 | 7.5 |
| 09:39 ET | 1862 | 7.535 |
| 09:41 ET | 6550 | 7.535 |
| 09:43 ET | 700 | 7.5 |
| 09:45 ET | 400 | 7.51 |
| 09:48 ET | 100 | 7.53 |
| 09:50 ET | 100 | 7.525 |
| 09:52 ET | 1200 | 7.5 |
| 09:54 ET | 400 | 7.47 |
| 09:56 ET | 161 | 7.445 |
| 09:57 ET | 430 | 7.4376 |
| 09:59 ET | 400 | 7.43 |
| 10:01 ET | 221 | 7.43 |
| 10:03 ET | 200 | 7.43 |
| 10:08 ET | 2762 | 7.445 |
| 10:10 ET | 1222 | 7.42 |
| 10:12 ET | 410 | 7.3999 |
| 10:14 ET | 417 | 7.4 |
| 10:15 ET | 200 | 7.41 |
| 10:17 ET | 525 | 7.44 |
| 10:19 ET | 3528 | 7.505 |
| 10:21 ET | 2685 | 7.52 |
| 10:24 ET | 4372 | 7.5 |
| 10:26 ET | 1916 | 7.4999 |
| 10:28 ET | 4034 | 7.51 |
| 10:30 ET | 13096 | 7.52 |
| 10:32 ET | 667 | 7.525 |
| 10:33 ET | 3443 | 7.54 |
| 10:35 ET | 800 | 7.55 |
| 10:39 ET | 600 | 7.575 |
| 10:42 ET | 872 | 7.58 |
| 10:44 ET | 100 | 7.59 |
| 10:46 ET | 1946 | 7.585 |
| 10:48 ET | 1051 | 7.6 |
| 10:50 ET | 400 | 7.6078 |
| 10:51 ET | 6503 | 7.62 |
| 10:53 ET | 1688 | 7.665 |
| 10:55 ET | 1860 | 7.64 |
| 10:57 ET | 5616 | 7.6 |
| 11:00 ET | 100 | 7.605 |
| 11:02 ET | 1406 | 7.62 |
| 11:04 ET | 4323 | 7.61 |
| 11:06 ET | 495 | 7.61 |
| 11:08 ET | 400 | 7.6 |
| 11:09 ET | 402 | 7.61 |
| 11:11 ET | 130 | 7.6 |
| 11:13 ET | 100 | 7.6 |
| 11:15 ET | 2803 | 7.59 |
| 11:20 ET | 1100 | 7.6001 |
| 11:22 ET | 1477 | 7.57 |
| 11:24 ET | 337 | 7.56 |
| 11:26 ET | 823 | 7.54 |
| 11:29 ET | 2402 | 7.56 |
| 11:31 ET | 412 | 7.555 |
| 11:33 ET | 100 | 7.56 |
| 11:36 ET | 852 | 7.575 |
| 11:38 ET | 651 | 7.58 |
| 11:40 ET | 1339 | 7.585 |
| 11:42 ET | 405 | 7.59 |
| 11:44 ET | 400 | 7.59 |
| 11:45 ET | 814 | 7.575 |
| 11:47 ET | 8414 | 7.6 |
| 11:51 ET | 1400 | 7.58 |
| 11:54 ET | 200 | 7.59 |
| 11:56 ET | 4107 | 7.61 |
| 11:58 ET | 2088 | 7.61 |
| 12:00 ET | 100 | 7.61 |
| 12:02 ET | 3000 | 7.62 |
| 12:03 ET | 518 | 7.63 |
| 12:05 ET | 465 | 7.64 |
| 12:07 ET | 600 | 7.65 |
| 12:09 ET | 424 | 7.645 |
| 12:12 ET | 300 | 7.655 |
| 12:14 ET | 100 | 7.655 |
| 12:16 ET | 200 | 7.655 |
| 12:18 ET | 100 | 7.655 |
| 12:20 ET | 1000 | 7.6597 |
| 12:21 ET | 2549 | 7.6897 |
| 12:23 ET | 200 | 7.685 |
| 12:25 ET | 2600 | 7.68 |
| 12:27 ET | 2999 | 7.68 |
| 12:30 ET | 1210 | 7.67 |
| 12:32 ET | 263 | 7.66 |
| 12:36 ET | 501 | 7.66 |
| 12:38 ET | 977 | 7.675 |
| 12:39 ET | 639 | 7.67 |
| 12:41 ET | 975 | 7.68 |
| 12:43 ET | 568 | 7.665 |
| 12:45 ET | 5858 | 7.6764 |
| 12:48 ET | 465 | 7.69 |
| 12:50 ET | 100 | 7.69 |
| 12:52 ET | 2511 | 7.69 |
| 12:54 ET | 408 | 7.68 |
| 12:56 ET | 112 | 7.66 |
| 12:57 ET | 611 | 7.68 |
| 12:59 ET | 1039 | 7.66 |
| 01:01 ET | 2857 | 7.6569 |
| 01:03 ET | 850 | 7.66 |
| 01:06 ET | 300 | 7.675 |
| 01:08 ET | 1238 | 7.665 |
| 01:10 ET | 1100 | 7.665 |
| 01:12 ET | 560 | 7.67 |
| 01:14 ET | 3674 | 7.695 |
| 01:15 ET | 1500 | 7.705 |
| 01:17 ET | 3569 | 7.67 |
| 01:19 ET | 1458 | 7.65 |
| 01:21 ET | 1045 | 7.635 |
| 01:24 ET | 2148 | 7.64 |
| 01:26 ET | 1250 | 7.6424 |
| 01:28 ET | 2007 | 7.63 |
| 01:30 ET | 200 | 7.6129 |
| 01:32 ET | 1372 | 7.615 |
| 01:33 ET | 200 | 7.625 |
| 01:35 ET | 618 | 7.62 |
| 01:37 ET | 1788 | 7.63 |
| 01:39 ET | 3815 | 7.625 |
| 01:42 ET | 100 | 7.63 |
| 01:44 ET | 400 | 7.645 |
| 01:46 ET | 100 | 7.65 |
| 01:48 ET | 335 | 7.65 |
| 01:50 ET | 435 | 7.645 |
| 01:51 ET | 732 | 7.64 |
| 01:53 ET | 5505 | 7.64 |
| 01:55 ET | 1357 | 7.635 |
| 01:57 ET | 300 | 7.635 |
| 02:00 ET | 1300 | 7.635 |
| 02:02 ET | 200 | 7.64 |
| 02:04 ET | 2191 | 7.61 |
| 02:06 ET | 100 | 7.61 |
| 02:08 ET | 400 | 7.61 |
| 02:09 ET | 200 | 7.6 |
| 02:11 ET | 872 | 7.615 |
| 02:13 ET | 962 | 7.615 |
| 02:15 ET | 100 | 7.62 |
| 02:18 ET | 200 | 7.615 |
| 02:20 ET | 675 | 7.615 |
| 02:22 ET | 421 | 7.615 |
| 02:24 ET | 318 | 7.615 |
| 02:26 ET | 600 | 7.62 |
| 02:27 ET | 100 | 7.63 |
| 02:29 ET | 385 | 7.63 |
| 02:31 ET | 300 | 7.625 |
| 02:33 ET | 71981 | 7.6093 |
| 02:36 ET | 6175 | 7.635 |
| 02:38 ET | 323 | 7.64 |
| 02:40 ET | 1593 | 7.64 |
| 02:42 ET | 749 | 7.65 |
| 02:44 ET | 600 | 7.66 |
| 02:45 ET | 1854 | 7.6567 |
| 02:47 ET | 1143 | 7.68 |
| 02:51 ET | 2508 | 7.68 |
| 02:54 ET | 1395 | 7.675 |
| 02:56 ET | 100 | 7.675 |
| 02:58 ET | 300 | 7.68 |
| 03:00 ET | 500 | 7.69 |
| 03:02 ET | 715 | 7.68 |
| 03:03 ET | 200 | 7.6799 |
| 03:05 ET | 800 | 7.675 |
| 03:07 ET | 200 | 7.69 |
| 03:09 ET | 778 | 7.69 |
| 03:12 ET | 1248 | 7.7 |
| 03:14 ET | 2795 | 7.67 |
| 03:16 ET | 100 | 7.68 |
| 03:20 ET | 7459 | 7.73 |
| 03:21 ET | 6755 | 7.7197 |
| 03:23 ET | 1868 | 7.72 |
| 03:25 ET | 3214 | 7.705 |
| 03:27 ET | 1836 | 7.705 |
| 03:30 ET | 1188 | 7.7099 |
| 03:32 ET | 2943 | 7.695 |
| 03:34 ET | 2121 | 7.695 |
| 03:36 ET | 2048 | 7.695 |
| 03:38 ET | 1360 | 7.6912 |
| 03:39 ET | 3029 | 7.695 |
| 03:41 ET | 1650 | 7.695 |
| 03:43 ET | 511 | 7.7 |
| 03:45 ET | 600 | 7.7 |
| 03:48 ET | 11344 | 7.7 |
| 03:50 ET | 917 | 7.71 |
| 03:52 ET | 5898 | 7.705 |
| 03:54 ET | 3031 | 7.7099 |
| 03:56 ET | 12379 | 7.745 |
| 03:57 ET | 34579 | 7.75 |
| 03:59 ET | 272006 | 7.74 |
Yesterday
Vir Biotechnology to Participate in the H.C. Wainwright 5th Annual Viral Hepatitis Virtual Conference, from 4:00PM ET on Thursday Oct 03, 2024 by Dow Jones
4:00PM ET on Thursday Oct 03, 2024 by Dow Jones
Sep 10, 2024
*DJ Vir Biotechnology Appoints Jason O'Byrne As Chief Financial Officer >VIR, from 8:05AM ET on Tuesday Sep 10, 2024 by Dow Jones
8:05AM ET on Tuesday Sep 10, 2024 by Dow JonesVir Biotechnology Appoints Jason O'Byrne as Chief Financial Officer, from 8:05AM ET on Tuesday Sep 10, 2024 by Dow Jones
8:05AM ET on Tuesday Sep 10, 2024 by Dow Jones
Sep 9, 2024
Sep 4, 2024
Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031, from 8:30AM ET on Wednesday Sep 04, 2024 by Dow Jones
8:30AM ET on Wednesday Sep 04, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Vir Biotechnology Inc | 1.0B | -2.2x | --- |
Prothena Corporation PLC | 903.5M | -16.7x | --- |
Zymeworks Inc | 866.1M | -8.3x | --- |
Immatics NV | 1.1B | -11.8x | --- |
Gyre Therapeutics Inc | 1.1B | -15.6x | --- |
Arcutis Biotherapeutics Inc | 1.2B | -4.6x | --- |
Company Information
Vir Biotechnology, Inc. is an immunology company, which is focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions. The Company's clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). It also has several preclinical candidates in its pipeline including those targeting influenza A and B, COVID-19, respiratory syncytial virus and human metapneumovirus (RSV and MPV), and human papillomavirus (HPV). The Company's pipeline includes VIR-1949, VIR-7229, VIR-2981, VIR-8190, and HIV Cure. It also engaged in developing tobevibart, a monoclonal antibody also known as VIR-3434, and Elebsiran, an siRNA also known as VIR-2218, for the treatment and suppression of chronic HDV. Its Elebsiran is an investigational HBV-targeted siRNA that reduces HBsAg, a protein which is required for the HDV viral life cycle.
Contact Information
- Headquarters
- 1800 OWENS STREET, SUITE 900SAN FRANCISCO, CA, United States 94158
- Phone
- 415-906-4324
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Vicki Sato
- Chief Executive Officer, Director
- Marianne De Backer
- Executive Vice President, Chief Technology Officer
- Ann Hanly
- Executive Vice President, Chief Scientific Officer
- Jennifer Towne
- Executive Vice President and Chief Business Officer
- Jeffrey Calcagno
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.0B |
|---|---|
Revenue (TTM) | $78.9M |
Shares Outstanding | 136.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.46 |
EPS | $-3.58 |
Book Value | $11.80 |
P/E Ratio | -2.2x |
Price/Sales (TTM) | 12.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -715.62% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
